Rami Hannoush, Ph. Additional Details: 1000 Ask Question Find a Lawyer. ’s Post Rami Hannoush, Ph. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Rami Hannoush, Ph. … | 80 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. D. Congrats Cameron! Like Reply 1 Reaction. We cover Rami's new role at Versant, the founding story of. D. interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures. Adam Catherman for valuable discussions. Congratulations to our own Rami Hannoush, Principal Scientist, Early Discovery Biochemistry, for being one of ten to receive the U. The small size of the chemical tag is meant to minimize interference with fatty acyltransferase substrate recognition and catalytic efficiency (Hannoush, 2015, Hannoush and Arenas-Ramirez, 2009). D. This button displays the currently selected search type. 2 From the Department of Early Discovery Biochemistry, Genentech, South San Francisco, California 94080 hannoush. … | 80 comments on LinkedInAt last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Fully funded PhD position in my group to investigate the mechanisms of cartilage regeneration Defining the molecular drivers of cartilage regeneration at…Biomarker interview with Rami Hannoush, Ph. Rami Hannoush, Ph. Biomarker interview with Rami Hannoush, Ph. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. ’s Post Rami Hannoush, Ph. Krylova, Rami N. Our group described u-alkyne fatty acids of various chain lengths (C10, C11, C13, C14, C16, and C18, with the alkyne group at the u position) (Figure 2) and showed the Wrapping up a 15-year discovery stint at Genentech back in the summer of 2021, Rami Hannoush was treated to a caffeine-fueled review of the latest work UCSF’s Jim Wells had been doing on protein degradation — one of the hottest fields in drug development. D. Rami Hannoush General Partner, Mubadala Capital | Life sciences company creation | Chief Scientific Officer 1y EditedRami Hannoush, Ph. Rami Hannoush serves as Venture Partner at Versant Ventures. ’s Post Rami Hannoush, Ph. Patrick Sexton, Monash University. D. D. ’s Post Rami Hannoush, Ph. D. D. D. I had the pleasure to join Rob Faulkner and Soo Romanoff on a. S. D. edu - Homepage. Born on September 20th, 1976 (47 years old)Rami Hannoush, Ph. Question: Add details. This button displays the currently selected search type. D. Healthcare VC at Versant | Life sciences company creation | Former R&D leader, Genentech | Former CEO, EpiBiologics 6mo Edited Report this post Great chat with. D. Clickable fatty acids coupled with in situ proximity ligation allow visualization of Wnt as it trafficks through the secretory pathway, defining roles for palmitoylation and glycosylation in. ’s Post Rami Hannoush, Ph. com. Manage my profile. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1mo Report this post Report Report. D. Lawyers - Get Listed Now! Get a free. doi: 10. Expand search. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Taipale, P. Rami Hannoush is the Chief Executive Officer (interim), President and a co-founder of EpiBiologics. That’s what it takes to walk across the stage as a Minds Matter NYC graduate. Rami Hannoush General Partner, Mubadala Capital | Life sciences company creation | Chief Scientific Officer 10mo EditedA multi-parametric method for quantitative analysis of cellular β-catenin protein levels in a rapid and high-throughput manner is described, which offers temporally resolved detection of Wnt-stimulated accumulation of β-Catenin, simultaneously detecting cell number, and it sheds light onto the kinetics of posttranslational stabilization ofβ-. D. "To our knowledge, no one has identified ligands that bind to the zymogen," said senior author Rami Hannoush, Genentech, South San Francisco, California. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. ’s Post Rami Hannoush, Ph. Rami Hannoush has 2 current jobs as General Partner at Mubadala Capital Ventures and Co-Founder at EpiBiologics. Rami Hannoush is the co-founder, interim CEO and president of EpiBiologics. Courtesy of EpiBiologics. rami@gene. Hannoush, Rami Nabil; Contributors. View the profiles of professionals named "Rami Hannoush" on LinkedIn. . … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. D. Lotte Simonsen, Novo Nordisk. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1y EditedRami Hannoush, Ph. Ribonucleic acids (RNA) are polymers of ribonucleotides linked together by 3',5. Sponsors and Exhibitors. rami@gene. In an interview with BioPharma Dive: Biotech and Pharma news, our co-founders Jim Wells and Rami Hannoush discussed the company's origin and EpiBiologics' differentiated protein degradation approach. , as Chief Scientific Officer, Thomas Graeber, Ph. Back. D. Auron was founded by a world class team of physicians and scientists with proven expertise in bringing effective differentiation therapies to patients. D. Leading strategies for expediting R&D and improving CMC efficiency. Rami Nabil Hannoush, Rami Hannoush, Ramin Hannoush. 2015. Hannoush, 5Wayne J. D. Stablix is pioneering an entirely new field of targeted deubiquitination therapeutics (TDT) to bring transformative medicines to patients with unmet medical need. The site facilitates research and collaboration in academic endeavors. We cover Rami's new role at. interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures. ’s Post Rami Hannoush, Ph. D. D. 05. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 6d EditedRami Hannoush, Ph. His current role includes leading interdisciplinary teams in lead discovery and research biology, with the overarching goal of developing therapeutics for the. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. Hannoush (hannoush. View Rami Hannoush's record in Watertown, MA including current phone number, address, relatives, background check report, and property record with Whitepages. 我于2006年加入了Genentech的早期发现生物化学部门，在哈佛大学的博士后团契和McGill Univer雷竞技app推荐码sity的博士学位完成后，2006年。At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Industry's largest & most renowned event to accelerate your oligo, peptide, mRNA therapeutics to market. D. Rami Hannoush, Ph. Its proprietary EpiTAC platform is a modular antibody-based system that enables the precise degradation of disease-driving membrane and extracellular proteins in a tissue-specific. Lawyers - Get Listed Now! Get a free. D. Simon Hansen 1 , Yingnan Zhang 1 , Sunhee Hwang 1 , Ahmad Nabhan 2 , Wanqing Li 1 , Jakob Fuhrmann 1 , Yvonne Kschonsak 3 , Lijuan Zhou 1 , Aaron H Nile 1 , Xinxin Gao 1 , Robert Piskol 3 , Felipe de Sousa E Melo 3 , Frederic J de Sauvage 3 , Rami N Hannoush 1 Contact Rami directly. The Section of Hematology/Oncology, within the Department of Internal Medicine, Max Rady College of Medicine, in affiliation with CancerCare Manitoba (CCMB) as the Department. Congratulations to our own Rami Hannoush, Principal Scientist, Early Discovery Biochemistry, for being one of ten to receive the U. He focuses on early. I am thankful for the LPs, founders, CEOs, team members who have remained steadfast partners over the years in using advanced technology to build a better… | 13 comments on LinkedInRami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. Corresponding author. ’s Post Rami Hannoush, Ph. Rami Hannoush, Ph. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Mubadala Capital Ventures General Partner Sep 2021. Rami N Hannoush, Ph. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. Back Submit. Rami Hannoush, Ph. 4 the Department of Early Discovery Biochemistry, Genentech, South San Francisco, California 94080, and hannoush. One of many physiological findings about lipid–protein interaction is that lipid modifications regulate some proteins generated by cancer genes, says Rami Hannoush, a chemical biologist at the. At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Anwesha Dey,4 Rami N. Damtra, Masad (Supervisor) Abstract. Rami N Hannoush Adjunct Professor, Chemical and Systems Biology Operations Print Profile Email Profile Bio Bio Professional Contact. View Rami Hannosh’s profile on LinkedIn, the world’s largest professional community. Hannoush and Arenas-Ramirez, 2009; Martin and Cravatt, 2009) also showed efficient bioorthogonal labeling of fatty acyl-ated proteins. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Lee-Karlon served as. Rami Hannoush, Ph. San Mateo, California, United States 4K followers 500+ connections See your mutual connections Join to follow Versant Ventures Harvard University Personal Website About -. Specific lab interests include Wnt signaling, protein. At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Many proteins have been found to be regulated through S-palmitoylation, a highly conserved process occurring in all eukaryotic organisms that involves the attachment of 16-carbon fatty acids onto cysteine residues via a reversible thioester linkage (Chamberlain and Shipston, 2015, Hannoush, 2015). Rami Hannoush is the Chief Executive Officer (interim), President and a co-founder of EpiBiologics. Rami Hannoush, EpiBiologics is building a protein degradation platform that targets membrane and extracellular [email protected]. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Rami Hannoush, Ph. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. View the profiles of professionals named "Rami D" on LinkedIn. Inventors: Eric Bourhis, Tim Cao, Rick Carano, Andrea Cochran, Mike Costa, Venita DeAlmeida, James Ernst, Yan Gong, Rami Hannoush, Paul Polakis, Bonnee Rubinfeld, Mark Solloway, Yan Wu METHODS AND COMPOSITIONS FOR MODULATING THE Wnt PATHWAY Protein palmitoylation plays diverse roles in regulating the trafficking, stability, and activity of cellular proteins. October 7-10, 2018 | Emerging Data on the Role of Wnt Biology in Cancer | 4 WEDNESDAY, OCTOBER 10 7:15 am Breakfast 9:00 am SESSION 8: Emerging Applications for Wnt Signaling in CancerRami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. Rami Hannoush. CSB 243: Biotechnology and Development of Therapeutics (Autumn)9 Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA, USA. com. D. The company intends to use the funds to advance the lead program toward clinical development and drive additional programs into drug discovery. Schneider, National Cancer Institute – Center for Cancer Research. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures. hannoush. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. When expanded it provides a list of search options that will switch the search inputs to match the. D. Back. Back. Rami N Hannoush is part of Stanford Profiles, official site for faculty, postdocs, students and staff information (Expertise, Bio, Research, Publications, and more). Profile Previews—Driven by the PitchBook Platform. D. D. D. We are dedicated to bridging ideas from academia with the cutting edge in biotechnology and translation. D. Fairbrother, ,* and Christian N. , Partner at Apollo Health Ventures, will join the Company as Board observers. This button displays the currently selected search type. EpiBiologics develops antibody-based targeted therapies against. Schneider, National Cancer Institute – Center for Cancer Research. Rami N. D. Inventors: Stefan Dengl, Rami Hannoush, Simon Theodor Hansen, Peter Michael Huelsmann, Robert Franklin Kelley, Hubert Kettenberger, Shrenik Chetan Mehta, Devin Brent Tesar HYALURONIC ACID BINDING DERIVATIVES OF VERSICAN (VG1) FOR LONG ACTING DELIVERY OF THERAPEUTICSRead all stories published by MubadalaVentures in 2022. Supplementary Figure 3 S6Taught/moderated by Ryan Watts, founder/CEO of Denali Therapeutics, and Rami Hannoush, former senior scientist at Genentech and now a partner at Mubadala, who bring in former / current colleagues to introduce each of the major functions (e. I had the pleasure to join Rob Faulkner and Soo. A fascinating approach to degrade membrane proteins/receptors. Back. D. com. com. Both structures reveal a dimeric arrangement of the CRD. Rami N. Rami Hannoush, Ph. Rami Hannoush is a co-founder, President and interim CEO of EpiBiologics. Aaron H Nile & Rami N Hannoush* Wnt proteins are critical regulators of signaling networks during embryonic development and in adult tissue homeostasis. Rami Hannoush, Ph. PMID: 26080277 DOI: 10. Rami Hannoush, Ph. The author has an hindex of 28, co-authored 68 publications receiving 2989 citations. Rami Hannoush Manage my profile. , for the launch of [email protected]. Welcome, Rami Hannoush, Ph. Healthcare VC at Versant | Life sciences company creation | Former R&D leader, Genentech | Former CEO, EpiBiologics 1y. Search for more papers by this author. Much less common are ribonucleic acids based on 2',5'-phosphodiester linkages (2',5'-RNA). D. Auron expands its leadership team with the appointments of David Millan, Ph. , USA) "Challenges and Emerging Approaches in Peptide Drug Discovery" 9:25 am - 9:40 am: Discussion. D. Rami Hannoush, co-founder and interim CEO of EpiBiologics, discusses the company’s platform technology, how its protein degradation approach expands the potential targets for its therapies; and. Operating Status Active. Rami Hannoush. Vlieghe et al. The . D. Published on July 20, 2022. Drug Discovery & Development Oncology Wnt and Stem. … | 79 comments on LinkedInRami Hannoush, Ph. Previously he was Pro-Rector for. Back. EpiBiologics is part of the Business Services industry, and located in California, United States. com. Last Funding Type Series A. Alanna Schepartz, The University of California, Berkeley. Ribonucleic acids (RNA) are polymers of ribonucleotides linked together by 3',5'-phosphodiester linkages and play a prominent role in protein biosynthesis. The authors would like to acknowledge Dr. Rami Hannoush, Ph. Last updated 6 months ago. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. - Most recent fund raising on April 28, 2023 raised $30,030,000 in EquityAt last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it…Rami Hannoush . 19th Ave New York, NY 95822, USA. Rights and permissions. hannoush. Back Submit. . J Pharm Sci 2022 07 10;111(7):1896-1910. D. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. has lived in San Mateo, CA Watertown, MA 1200 Massachusetts Ave, Cambridge, MA 02138 Foster City, CA. D General Information. Phone and address: 35 28Th Ave #300, San Mateo, CA 94403. com. D. When expanded it provides a list of search options that will switch the search inputs to match the. Congratulations to Rami Hannoush, Ph. Gemma met Rami in 2011 when she was just starting out on the reality show The Only Way Is Essex. and Jim Wells to the portfolio. Headquarters Regions San Francisco Bay Area, Silicon Valley, West [email protected] N Hannoush, Ph. ACS Chemical Biology editors highlight articles from Volume 4, Issue 7, and speak with authors Rami Hannoush and Domagoj Vucic. D. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 3mo Edited Report this post At last, after 43 years since the discovery of the Wnt gene, the structure of the ternary Wnt – Frizzled – LRP6 signaling complex is reported here, and it provides a blueprint that. Rami Hannoush serves as Venture Partner at Versant Ventures. Hannoush is an academic researcher from Genentech. Healthcare VC | Life sciences company creation 6dTherapeutics. D. Rami Hannoush is Member Board Of Directors of Neumora Therapeutics. Back. Jumi Shin, University of Toronto. D. Mr. This paper describes a multi-parametric method for quantitative analysis of cellular beta-catenin protein levels in a rapid and high-throughput manner. ’s Post Rami Hannoush, Ph. rami@gene. Founded in 2022 and led by CEO Dr. ’s Post Rami Hannoush, Ph. Sponsors and Exhibitors. BSMB Spring meeting 2022: "Interactions between Lipids/derivatives and the ECM: pre-clinical and clinical relevance" Registration for BSMB members is FREE, £10 and £30 respectively for student. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. 19th Ave New York, NY 95822, USA. D. Human OS cell lines (MNNG/HOS, MG-63, and U2-OS) were treated with increasing concentrations of dynasore or cisplatin, and then the cell. Number of Current Jobs 2. EpiBiologics's CEO is Rami Hannoush What does EpiBiologics do? Founded in 2022, EpiBiologics is a biotechnology company with a focus on antibody-based protein degradation. The seven-transmembrane-spanning receptors of the FZD 1–10 class are bound and activated by the WNT family of lipoglycoproteins, thereby inducing a complex network of signaling pathways. … | 76 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. com. Back. Founded in 2022 and led by CEO Dr. Yen, founder and CEO. 120. Rami Hannoush, Ph. When expanded it provides a list of search options that will switch the search inputs to match the. 025 Abstract Fatty acylation of proteins is a versatile co-translational or post-translational modification that plays a key role in human physiology and disease. The assay offers temporally resolved detection of Wnt-stimulated accumulation of beta-catenin, simultaneously detecting cell number, and it sheds light onto the kinetics of posttranslational. Rami Hannoush, Ph. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1w EditedRami Hannoush, Ph. Rami Hannoush is a co-founder, President and interim CEO of EpiBiologics. Dr. Expand search. EpiBiologics’s CEO is Rami Hannoush Who are EpiBiologics key employees? Some of EpiBiologics key employees are Craig Lichtenstein Where is EpiBiologics located? EpiBiologics’s headquarters are located at 1900 Alameda De Las Pulgas Ste 250, San Mateo, California, 94403, United States How do I contact. ’s Post Rami Hannoush, Ph. D. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 7mo Report this post What are some of the factors that contribute to aging? And could we identify the specific mechanisms by which these factors impair tissue regeneration?The image depicts palmitoylated Wnt proteins (rendered from PDB file 4F0A) en route to secretion outside the cell. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Rami Hannoush, Ph. There are 3 professionals named "Rami Hannoush", who use LinkedIn to exchange information, ideas, and opportunities. He also recently joined Versant Ventures (as a venture partner) where he. She joined Altos at its initiation in 2021 and wasPostdoctoral Research Fellow, Chemical Biology and Biochemistry, Rami Hannoush lab, Genentech Research chez Roche in South San Francisco. Beitrag von Rami Hannoush, Ph. Rami Hannoush Ph. We cover his grad school/post-doc training in chemical biology, 15+ years as a group leader Genentech and. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. , Partner at Apollo Health Ventures, will join the Company as Board observers. D. Less time bookkeeping means more time to pursue your. San Mateo, CA. Yen, founder and CEO. , South San Francisco, CA, USA. D. Lee-Karlon left another Bay Area biotech company, Altos Labs, in June, according to her LinkedIn. Great chat with Ron Leuty from San Francisco Business Times to share our story on building EpiBiologics #companybuilding #degradation | 28 comments on LinkedInComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. D. ’s Post Rami Hannoush, Ph. According to LinkedIn Rami Hannoush started working on 2006, then the employee has changed 9 companies and 12 jobs. Rami N. D. hannoush. We cover Rami's new role at Versant, the founding story of. D. D. … | 79 comments on LinkedInRami Hannoush, Ph. The design of clickable fatty acid probes is based on the introduction of a small chemical tag (alkyne or azide) at the ω or methyl end of the fatty acid (Figure 2). com. D. 1038/nchembio. Scheme 2 S3 . Name & Title Social Contact Info; Craig Lichtenstein. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 2mo Report this post Report Report. Healthcare VC | Life sciences company creation | Former R&D leader, GenentechComing out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. D. Rami Hannoush, Ph. Hannoush and Arenas-Ramirez, 2009; Martin and Cravatt, 2009) also showed efficient bioorthogonal labeling of fatty acyl-Wrapping up a 15-year discovery stint at Genentech back in the summer of 2021, Rami Hannoush was treated to a caffeine-fueled review of the latest work UCSF’s Jim Wells had been doing on protein degradation — one of the hottest fields in drug development. Biomarker interview with Rami Hannoush, Ph. D. Founders James Wells, Rami Hannoush. Healthcare VC | Life sciences company creation | Former R&D leader, Genentech 1w EditedRami Hannoush; Found 5 results for your query: Rami Hannoush in the United States of America. Drug Discov. ’s Post Rami Hannoush, Ph. Dr. His current role includes leading interdisciplinary teams in lead discovery and research biology, with the overarching goal of developing therapeutics. D. He brings a unique blend of investment experience and deep drug discovery expertise to our. Related to: Rana Hannoush, 42. Rami Hannoush, Ph. Supplementary information. Coming out of stealth mode, I'm thrilled to announce the unveiling of EpiBiologics, a biotech company advancing a next-generation protein degradation platform. Rami Hannoush, Ph. rami@gene. Materials availability This study did not generate new unique reagents. Inventors: Eric Bourhis, Tim Cao, Rick Carano, Andrea Cochran, Mike Costa, Venita DeAlmeida, James Ernst, Yan Gong, Rami Hannoush, Paul Polakis, Bonnee Rubinfeld, Mark Solloway, Yan Wu Ask a Lawyer. D. … | 79 comments on LinkedInRami Hannoush, Ph. Biomarker interview with Rami Hannoush, Ph. D. Healthcare VC | Life sciences company creation 6dRami Hannoush, Ph. DOI: 10. On average, Rami Hannoush works for one company for 2 years 7 months. interim CEO and co-founder of EpiBiologics and venture partner at Versant Ventures. Proud to partner with a great team to systematically explore the untapped therapeutic potential of…“We would like to thank Rami Hannoush for his leadership as co-founder and interim CEO and look forward to an exciting next stage of growth for EpiBiologics under Ann’s leadership. Jobs. Healthcare VC | Life sciences company creation 6 TageThank you Ayman, Alaa, and Rami for your trust and support! Could not have asked for better partners. ’s Post Rami Hannoush, Ph. ’s Post Rami Hannoush, Ph. … | 79 comments on LinkedInRami Hannoush, Ph. EpiBiologics, Inc. Healthcare VC at Versant | Life sciences company creation | Former R&D leader, Genentech | Former CEO, EpiBiologics 1y. “Dysregulation of normal cellular differentiation processes can alter normal cell biology leading to tumor formation and progression,” said Dr. 1038/nchembio.